Molecule Name |
DB09299
|
DrugBank Groups |
Approved
|
Cluster No |
1166
|
Smiles |
P(=O)(OC1(=CC=CC=C1))(NC(C(=O)OC(C)C)C)COC(CN3(C2(=NC=NC(=C2N=C3)N)))C
|
Download |
mol2, pdbqt
|
TPSA |
153,29
|
Non-H Atoms |
33
|
Non-C/H Atoms |
12
|
Metal-Atoms |
0
|
Electronegative Atoms |
12
|
Stereo Centers |
3
|
Rotatable Bonds |
11
|
Rings Closures |
3
|
Small Rings |
3
|
Aromatic Rings |
3
|
Aromatic Atoms |
15
|
sp3-Atoms |
13
|
Symmetric atoms |
3
|
cLogS |
-5,723
|
MW |
476,472
|
cLogP |
1,4328
|
HBA |
11
|
HBD |
2
|
Ro5 violations |
1
|
Druglikeness |
-16,097
|
DrugScore |
0,256815930158524
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2-
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-3,8776
|
Caco-2 Permeability 2 |
0,196
|
Subcellular localization |
Lysosome
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,2562
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,574
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,6588
|
Carcinogenicity (Three-class) |
Non-required
|